http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015024389-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76048fc47c9088eed637db0f3e957760
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_838e3daf5b81c4a2adc717278eb7f749
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efb8cb4e6ee6d1a16d7b6a7ec55377b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c578fa2b3c88fe7da4fa9072202ac38b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_457031bfd2083a7789313a20b5ed550f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2012-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_781ad3f23150cfeb7fd5525764bfccd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49a67f29b83101a9d221e95ca008fc1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca61c8087925ec3fff5eed31eb2d401e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcec68f1436de728eaafda82fe8e0e8c
publicationDate 2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015024389-A1
titleOfInvention Method for detecting bladder cancer cells, primer used in method for detecting bladder cancer cells, and bladder cancer marker
abstract Provided are: a method for detecting bladder cancer with high detection sensitivity, which has a high specificity for bladder cancer and is capable of detecting bladder cancer tissues with low grade of malignancy; and a bladder cancer marker. A method for detecting bladder cancer cells, which comprises detection of the amount of expressed bladder cancer marker in a subject sample collected from a subject, said bladder cancer marker being composed of one or more miRNAs selected from among miR-124, miR-9 and miR-137; a primer which is used in the method for detecting bladder cancer cells; and a bladder cancer marker.
priorityDate 2011-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5047209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4775

Total number of triples: 34.